Abbeyfield Grove House DCA was rated Requires Improvement overall following its April 2017 inspection, with a regulatory breach (Regulation 12) identified due to persistent medication management failures that had been identified internally but not acted upon. The service demonstrated genuine strengths in caring, effective, and responsive practice, with staff praised by people using the service, but governance and leadership were undermined by the absence of a registered manager and an audit system that failed to drive timely corrective action.
Abbeyfield Grove House DCA achieved a Good rating across all five key questions at its July 2018 inspection, having successfully remediated a previous medicines management breach identified in April 2017. Minor shortfalls remained in topical cream documentation and end-of-life care planning, but the service demonstrated strong person-centred care, effective leadership and robust quality assurance systems.